메뉴 건너뛰기




Volumn 11, Issue 1, 2013, Pages 78-98

Small cell lung cancer: Clinical practice guidelines in oncology

(26)  Kalemkerian, Gregory P a   Akerley, Wallace b   Bogner, Paul c   Borghaei, Hossein d   Chow, Laura QM e   Downey, Robert J f   Gandhi, Leena g   Ganti, Apar Kishor P h   Govindan, Ramaswamy i   Grecula, John C j   Hayman, James a   Heist, Rebecca Suk k   Horn, Leora l   Jahan, Thierry m   Koczywas, Marianna n   Loo, Billy W o   Merritt, Robert E o   Moran, Cesar A p   Niell, Harvey B q   O'Malley, Janis r   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMRUBICIN; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CONIVAPTAN; CREATININE; CYCLOPHOSPHAMIDE; DEMECLOCYCLINE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; LACTATE DEHYDROGENASE; NAVELBINE; OPIATE; PACLITAXEL; TEMOZOLOMIDE; TOLVAPTAN; TOPOTECAN; VINCRISTINE;

EID: 84874589027     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0011     Document Type: Article
Times cited : (331)

References (143)
  • 1
    • 77954345275 scopus 로고    scopus 로고
    • Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    • Oberg K, Hellman P, Kwekkeboom D, Jelic S. Neuroendocrine bronchial and thymic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl 5):v220-222.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 5
    • Oberg, K.1    Hellman, P.2    Kwekkeboom, D.3    Jelic, S.4
  • 2
    • 33750603100 scopus 로고    scopus 로고
    • Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
    • Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
    • (2006) J Clin Oncol , vol.24 , pp. 4539-4544
    • Govindan, R.1    Page, N.2    Morgensztern, D.3
  • 3
    • 33846013518 scopus 로고    scopus 로고
    • Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database [abstract]
    • Abstract 7082
    • Navada S, Lai P, Schwartz A, Kalemkerian G. Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database [abstract]. J Clin Oncol 2006;24(Suppl 18):Abstract 7082.
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL. 18
    • Navada, S.1    Lai, P.2    Schwartz, A.3    Kalemkerian, G.4
  • 5
    • 33947582831 scopus 로고    scopus 로고
    • A review of first-line treatment for small-cell lung cancer
    • Murray N, Turrisi AT III. A review of first-line treatment for small-cell lung cancer. J Thorac Oncol 2006;1:270-278.
    • (2006) J Thorac Oncol , vol.1 , pp. 270-278
    • Murray, N.1    Turrisi III, A.T.2
  • 6
    • 58049101796 scopus 로고    scopus 로고
    • Management of small-cell lung cancer: Incremental changes but hope for the future
    • Williston Park
    • Hann CL, Rudin CM. Management of small-cell lung cancer: incremental changes but hope for the future. Oncology (Williston Park) 2008;22:1486-1492.
    • (2008) Oncology , vol.22 , pp. 1486-1492
    • Hann, C.L.1    Rudin, C.M.2
  • 7
    • 1942471677 scopus 로고    scopus 로고
    • Basic treatment considerations using chemotherapy for patients with small cell lung cancer
    • Johnson BE, Janne PA. Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am 2004;18:309-322.
    • (2004) Hematol Oncol Clin North Am , vol.18 , pp. 309-322
    • Johnson, B.E.1    Janne, P.A.2
  • 8
    • 75149169449 scopus 로고    scopus 로고
    • Treatment of extensive-stage small cell lung carcinoma: Current status and future prospects
    • Demedts IK, Vermaelen KY, van Meerbeeck JP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J 2010;35:202-215.
    • (2010) Eur Respir J , vol.35 , pp. 202-215
    • Demedts, I.K.1    Vermaelen, K.Y.2    Van Meerbeeck, J.P.3
  • 9
    • 0037504527 scopus 로고    scopus 로고
    • Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival
    • Videtic GM, Stitt LW, Dar AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003;21:1544-1549.
    • (2003) J Clin Oncol , vol.21 , pp. 1544-1549
    • Videtic, G.M.1    Stitt, L.W.2    Dar, A.R.3
  • 10
    • 0037328006 scopus 로고    scopus 로고
    • Pathology of small cell carcinoma of the lung
    • Zakowski MF. Pathology of small cell carcinoma of the lung. Semin Oncol 2003;30:3-8.
    • (2003) Semin Oncol , vol.30 , pp. 3-8
    • Zakowski, M.F.1
  • 11
    • 4344689150 scopus 로고    scopus 로고
    • Small-cell carcinomas of the gastrointestinal tract: A review
    • Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004;22:2730-2739.
    • (2004) J Clin Oncol , vol.22 , pp. 2730-2739
    • Brenner, B.1    Tang, L.H.2    Klimstra, D.S.3    Kelsen, D.P.4
  • 12
    • 0030961496 scopus 로고    scopus 로고
    • Extrapulmonary small cell carcinoma
    • Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79:1729-1736.
    • (1997) Cancer , vol.79 , pp. 1729-1736
    • Galanis, E.1    Frytak, S.2    Lloyd, R.V.3
  • 13
    • 0026747929 scopus 로고
    • Extrapulmonary and pulmonary small-cell carcinoma: Tumor biology, therapy, and outcome
    • Remick SC, Ruckdeschel JC. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome. Med Pediatr Oncol 1992;20:89-99.
    • (1992) Med Pediatr Oncol , vol.20 , pp. 89-99
    • Remick, S.C.1    Ruckdeschel, J.C.2
  • 14
    • 0024386775 scopus 로고
    • Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies
    • Johnson BE, Whang-Peng J, Naylor SL, et al. Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 1989;81:1223-1228.
    • (1989) J Natl Cancer Inst , vol.81 , pp. 1223-1228
    • Johnson, B.E.1    Whang-Peng, J.2    Naylor, S.L.3
  • 15
    • 0028073366 scopus 로고
    • The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies
    • Guinee DG Jr, Fishback NF, Koss MN, et al. The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. Am J Clin Pathol 1994;102:406-414.
    • (1994) Am J Clin Pathol , vol.102 , pp. 406-414
    • Guinee Jr., D.G.1    Fishback, N.F.2    Koss, M.N.3
  • 16
    • 78649390219 scopus 로고    scopus 로고
    • Advances in neuroendocrine lung tumors
    • Travis WD. Advances in neuroendocrine lung tumors. Ann Oncol 2010;21(Suppl 7):vii65-71.
    • (2010) Ann Oncol , vol.21 , Issue.SUPPL. 7
    • Travis, W.D.1
  • 17
    • 47149104096 scopus 로고    scopus 로고
    • Bronchopulmonary neuroendocrine tumors
    • Gustafsson BI, Kidd M, Chan A, et al. Bronchopulmonary neuroendocrine tumors. Cancer 2008;113:5-21.
    • (2008) Cancer , vol.113 , pp. 5-21
    • Gustafsson, B.I.1    Kidd, M.2    Chan, A.3
  • 18
    • 18144369998 scopus 로고    scopus 로고
    • Distinguishing carcinoid tumor from small cell carcinoma of the lung: Correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program
    • Renshaw AA, Haja J, Lozano RL, Wilbur DC. Distinguishing carcinoid tumor from small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005;129:614-618.
    • (2005) Arch Pathol Lab Med , vol.129 , pp. 614-618
    • Renshaw, A.A.1    Haja, J.2    Lozano, R.L.3    Wilbur, D.C.4
  • 19
    • 79961108629 scopus 로고    scopus 로고
    • Reduced lung-cancer mortality with low-dose computed tomographic screening
    • Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
    • (2011) N Engl J Med , vol.365 , pp. 395-409
    • Aberle, D.R.1    Adams, A.M.2    Berg, C.D.3
  • 20
    • 79953008247 scopus 로고    scopus 로고
    • Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers
    • Cuffe S, Moua T, Summerfield R, et al. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol 2011;6:818-822.
    • (2011) J Thorac Oncol , vol.6 , pp. 818-822
    • Cuffe, S.1    Moua, T.2    Summerfield, R.3
  • 21
    • 33747602338 scopus 로고    scopus 로고
    • Paraneoplastic syndromes associated with small cell lung cancer
    • Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw 2006;4:631-638.
    • (2006) J Natl Compr Canc Netw , vol.4 , pp. 631-638
    • Gandhi, L.1    Johnson, B.E.2
  • 22
    • 79953119082 scopus 로고    scopus 로고
    • Small-cell lung cancer-associated autoantibodies: Potential applications to cancer diagnosis, early detection, and therapy
    • Kazarian M, Laird-Offringa IA. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer 2011;10:33.
    • (2011) Mol Cancer , vol.10 , pp. 33
    • Kazarian, M.1    Laird-Offringa, I.A.2
  • 23
    • 0031017013 scopus 로고    scopus 로고
    • Paraneoplastic syndromes associated with small cell lung cancer
    • Marchioli CC, Graziano SL. Paraneoplastic syndromes associated with small cell lung cancer. Chest Surg Clin N Am 1997;7:65-80.
    • (1997) Chest Surg Clin N Am , vol.7 , pp. 65-80
    • Marchioli, C.C.1    Graziano, S.L.2
  • 24
    • 52049103838 scopus 로고    scopus 로고
    • Screening for small-cell lung cancer: A follow-up study of patients with Lambert-Eaton myasthenic syndrome
    • Titulaer MJ, Wirtz PW, Willems LN, et al. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. J Clin Oncol 2008;26:4276-4281.
    • (2008) J Clin Oncol , vol.26 , pp. 4276-4281
    • Titulaer, M.J.1    Wirtz, P.W.2    Willems, L.N.3
  • 25
    • 0029811225 scopus 로고    scopus 로고
    • Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma
    • Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol 1996;40:739-749.
    • (1996) Ann Neurol , vol.40 , pp. 739-749
    • Meriney, S.D.1    Hulsizer, S.C.2    Lennon, V.A.3    Grinnell, A.D.4
  • 26
    • 0034981452 scopus 로고    scopus 로고
    • Anti-Hu-associated paraneoplastic encephalomyelitis: Analysis of 200 patients
    • Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-1148.
    • (2001) Brain , vol.124 , pp. 1138-1148
    • Graus, F.1    Keime-Guibert, F.2    Rene, R.3
  • 27
    • 0027461249 scopus 로고
    • Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications
    • Delisle L, Boyer MJ, Warr D, et al. Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 1993;153:746-752.
    • (1993) Arch Intern Med , vol.153 , pp. 746-752
    • Delisle, L.1    Boyer, M.J.2    Warr, D.3
  • 28
    • 0030687945 scopus 로고    scopus 로고
    • A prospective study of patients with lung cancer and hyponatremia of malignancy
    • Johnson BE, Chute JP, Rushin J, et al. A prospective study of patients with lung cancer and hyponatremia of malignancy. Am J Respir Crit Care Med 1997;156:1669-1678.
    • (1997) Am J Respir Crit Care Med , vol.156 , pp. 1669-1678
    • Johnson, B.E.1    Chute, J.P.2    Rushin, J.3
  • 29
    • 84862846656 scopus 로고    scopus 로고
    • Diagnosis and management of hyponatremia in cancer patients
    • Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist 2012;17:756-765.
    • (2012) Oncologist , vol.17 , pp. 756-765
    • Castillo, J.J.1    Vincent, M.2    Justice, E.3
  • 30
    • 77956383370 scopus 로고    scopus 로고
    • Paraneoplastic syndromes: An approach to diagnosis and treatment
    • Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 2010;85:838-854.
    • (2010) Mayo Clin Proc , vol.85 , pp. 838-854
    • Pelosof, L.C.1    Gerber, D.E.2
  • 31
    • 33751005260 scopus 로고    scopus 로고
    • Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
    • Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099-2112.
    • (2006) N Engl J Med , vol.355 , pp. 2099-2112
    • Schrier, R.W.1    Gross, P.2    Gheorghiade, M.3
  • 32
    • 45349106231 scopus 로고    scopus 로고
    • Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: Subgroup analysis of a randomized, controlled study
    • Verbalis JG, Zeltser D, Smith N, et al. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf) 2008;69:159-168.
    • (2008) Clin Endocrinol (Oxf) , vol.69 , pp. 159-168
    • Verbalis, J.G.1    Zeltser, D.2    Smith, N.3
  • 33
    • 0036753654 scopus 로고    scopus 로고
    • Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease?
    • Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer-what limits limited disease? Lung Cancer 2002;37:271-276.
    • (2002) Lung Cancer , vol.37 , pp. 271-276
    • Micke, P.1    Faldum, A.2    Metz, T.3
  • 34
    • 84860317809 scopus 로고    scopus 로고
    • Staging and imaging of small cell lung cancer
    • Kalemkerian GP. Staging and imaging of small cell lung cancer. Cancer Imaging 2011;11:253-258.
    • (2011) Cancer Imaging , vol.11 , pp. 253-258
    • Kalemkerian, G.P.1
  • 35
    • 37349068491 scopus 로고    scopus 로고
    • The International Association for the Study of Lung Cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer
    • Shepherd FA, Crowley J, Van Houtte P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007;2:1067-1077.
    • (2007) J Thorac Oncol , vol.2 , pp. 1067-1077
    • Shepherd, F.A.1    Crowley, J.2    Van Houtte, P.3
  • 36
    • 67049161492 scopus 로고    scopus 로고
    • The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition
    • Ignatius Ou SH, Zell JA. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition. J Thorac Oncol 2009;4:300-310.
    • (2009) J Thorac Oncol , vol.4 , pp. 300-310
    • Ignatius Ou, S.H.1    Zell, J.A.2
  • 37
    • 69549097677 scopus 로고    scopus 로고
    • The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer
    • Vallieres E, Shepherd FA, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2009;4:1049-1059.
    • (2009) J Thorac Oncol , vol.4 , pp. 1049-1059
    • Vallieres, E.1    Shepherd, F.A.2    Crowley, J.3
  • 39
    • 34548457234 scopus 로고    scopus 로고
    • The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours
    • Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
    • (2007) J Thorac Oncol , vol.2 , pp. 706-714
    • Goldstraw, P.1    Crowley, J.2    Chansky, K.3
  • 40
    • 67650436288 scopus 로고    scopus 로고
    • NCCN task force: Clinical utility of PET in a variety of tumor types
    • Podoloff DA, Ball DW, Ben-Josef E, et al. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw 2009;7(Suppl 2):S1-26.
    • (2009) J Natl Compr Canc Netw , vol.7 , Issue.SUPPL. 2
    • Podoloff, D.A.1    Ball, D.W.2    Ben-Josef, E.3
  • 41
    • 4344626094 scopus 로고    scopus 로고
    • Positron emission tomography in limited-stage small-cell lung cancer: A prospective study
    • Bradley JD, Dehdashti F, Mintun MA, et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004;22:3248-3254.
    • (2004) J Clin Oncol , vol.22 , pp. 3248-3254
    • Bradley, J.D.1    Dehdashti, F.2    Mintun, M.A.3
  • 42
    • 33846844826 scopus 로고    scopus 로고
    • 18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)
    • 18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Am J Clin Oncol 2007;30:45-50.
    • (2007) Am J Clin Oncol , vol.30 , pp. 45-50
    • Kut, V.1    Spies, W.2    Spies, S.3
  • 43
    • 78149277688 scopus 로고    scopus 로고
    • High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer
    • Azad A, Chionh F, Scott AM, et al. High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer. Mol Imaging Biol 2010;12:443-451.
    • (2010) Mol Imaging Biol , vol.12 , pp. 443-451
    • Azad, A.1    Chionh, F.2    Scott, A.M.3
  • 44
    • 33847259140 scopus 로고    scopus 로고
    • A prospective study of PET/CT in initial staging of small-cell lung cancer: Comparison with CT, bone scintigraphy and bone marrow analysis
    • Fischer BM, Mortensen J, Langer SW, et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 2007;18:338-345.
    • (2007) Ann Oncol , vol.18 , pp. 338-345
    • Fischer, B.M.1    Mortensen, J.2    Langer, S.W.3
  • 45
    • 19944428215 scopus 로고    scopus 로고
    • Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer
    • Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004;31:1614-1620.
    • (2004) Eur J Nucl Med Mol Imaging , vol.31 , pp. 1614-1620
    • Brink, I.1    Schumacher, T.2    Mix, M.3
  • 46
    • 1542787390 scopus 로고    scopus 로고
    • Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer
    • Kamel EM, Zwahlen D, Wyss MT, et al. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003;44:1911-1917.
    • (2003) J Nucl Med , vol.44 , pp. 1911-1917
    • Kamel, E.M.1    Zwahlen, D.2    Wyss, M.T.3
  • 47
    • 39149131711 scopus 로고    scopus 로고
    • Can positron emission tomography be used as a staging tool for small-cell lung cancer?
    • Vinjamuri M, Craig M, Campbell-Fontaine A, et al. Can positron emission tomography be used as a staging tool for small-cell lung cancer? Clin Lung Cancer 2008;9:30-34.
    • (2008) Clin Lung Cancer , vol.9 , pp. 30-34
    • Vinjamuri, M.1    Craig, M.2    Campbell-Fontaine, A.3
  • 48
    • 67649184760 scopus 로고    scopus 로고
    • Prognostic factors differ by tumor stage for small cell lung cancer: A pooled analysis of North Central Cancer Treatment Group trials
    • Foster NR, Mandrekar SJ, Schild SE, et al. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer 2009;115:2721-2731.
    • (2009) Cancer , vol.115 , pp. 2721-2731
    • Foster, N.R.1    Mandrekar, S.J.2    Schild, S.E.3
  • 49
    • 0025003393 scopus 로고
    • Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient Southwest Oncology Group data base
    • Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990;8:1563-1574.
    • (1990) J Clin Oncol , vol.8 , pp. 1563-1574
    • Albain, K.S.1    Crowley, J.J.2    Leblanc, M.3    Livingston, R.B.4
  • 50
    • 0034059515 scopus 로고    scopus 로고
    • Predictive and prognostic factors in small cell lung cancer: Current status
    • Yip D, Harper PG. Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 2000;28:173-185.
    • (2000) Lung Cancer , vol.28 , pp. 173-185
    • Yip, D.1    Harper, P.G.2
  • 51
    • 0031906013 scopus 로고    scopus 로고
    • Brain-only metastases of small cell lung cancer; Efficacy of whole brain radiotherapy. An EORTC phase II study
    • Postmus PE, Haaxma-Reiche H, Gregor A, et al. Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study. Radiother Oncol 1998;46:29-32.
    • (1998) Radiother Oncol , vol.46 , pp. 29-32
    • Postmus, P.E.1    Haaxma-Reiche, H.2    Gregor, A.3
  • 53
    • 0345872083 scopus 로고    scopus 로고
    • Multidisciplinary management of lung cancer
    • Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392.
    • (2004) N Engl J Med , vol.350 , pp. 379-392
    • Spira, A.1    Ettinger, D.S.2
  • 54
    • 0036197829 scopus 로고    scopus 로고
    • Management of small cell lung cancer
    • Johnson BE. Management of small cell lung cancer. Clin Chest Med 2002;23:225-239.
    • (2002) Clin Chest Med , vol.23 , pp. 225-239
    • Johnson, B.E.1
  • 55
    • 0022409779 scopus 로고
    • VP-16 and cisplatin as first-line therapy for small-cell lung cancer
    • Evans WK, Shepherd FA, Feld R, et al. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol 1985;3:1471-1477.
    • (1985) J Clin Oncol , vol.3 , pp. 1471-1477
    • Evans, W.K.1    Shepherd, F.A.2    Feld, R.3
  • 56
    • 26644438582 scopus 로고    scopus 로고
    • Small-cell lung cancer
    • Jackman DM, Johnson BE. Small-cell lung cancer. Lancet 2005;366:1385-1396.
    • (2005) Lancet , vol.366 , pp. 1385-1396
    • Jackman, D.M.1    Johnson, B.E.2
  • 57
    • 0037115426 scopus 로고    scopus 로고
    • Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up
    • Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 2002;20:4665-4672.
    • (2002) J Clin Oncol , vol.20 , pp. 4665-4672
    • Sundstrom, S.1    Bremnes, R.M.2    Kaasa, S.3
  • 58
    • 0023472047 scopus 로고
    • Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer
    • Bishop JF, Raghavan D, Stuart-Harris R, et al. Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. J Clin Oncol 1987;5:1574-1578.
    • (1987) J Clin Oncol , vol.5 , pp. 1574-1578
    • Bishop, J.F.1    Raghavan, D.2    Stuart-Harris, R.3
  • 59
    • 0027992052 scopus 로고
    • Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study
    • Skarlos DV, Samantas E, Kosmidis P, et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 1994;5:601-607.
    • (1994) Ann Oncol , vol.5 , pp. 601-607
    • Skarlos, D.V.1    Samantas, E.2    Kosmidis, P.3
  • 60
    • 34447329621 scopus 로고    scopus 로고
    • Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
    • Okamoto H, Watanabe K, Kunikane H, et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer 2007;97:162-169.
    • (2007) Br J Cancer , vol.97 , pp. 162-169
    • Okamoto, H.1    Watanabe, K.2    Kunikane, H.3
  • 61
    • 84863752868 scopus 로고    scopus 로고
    • Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: The COCIS meta-analysis of individual patient data
    • Rossi A, Di Maio M, Chiodini P, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012;30:1692-1698.
    • (2012) J Clin Oncol , vol.30 , pp. 1692-1698
    • Rossi, A.1    Di Maio, M.2    Chiodini, P.3
  • 62
    • 0037050354 scopus 로고    scopus 로고
    • Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
    • Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346:85-91.
    • (2002) N Engl J Med , vol.346 , pp. 85-91
    • Noda, K.1    Nishiwaki, Y.2    Kawahara, M.3
  • 63
    • 66349102227 scopus 로고    scopus 로고
    • Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: Clinical and pharmacogenomic results from SWOG S0124
    • Lara PN Jr, Natale R, Crowley J, et al. Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol 2009;27:2530-2535.
    • (2009) J Clin Oncol , vol.27 , pp. 2530-2535
    • Lara Jr., P.N.1    Natale, R.2    Crowley, J.3
  • 64
    • 33646447066 scopus 로고    scopus 로고
    • Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer 10.1200/JCO.2005.04.8595
    • Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer 10.1200/JCO.2005.04.8595. J Clin Oncol 2006;24:2038-2043.
    • (2006) J Clin Oncol , vol.24 , pp. 2038-2043
    • Hanna, N.1    Bunn Jr., P.A.2    Langer, C.3
  • 65
    • 33645327676 scopus 로고    scopus 로고
    • A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer
    • Schmittel A, Fischer von Weikersthal L, Sebastian M, et al. A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin treatment in patients with extended disease small-cell lung cancer. Ann Oncol 2006;17:663-667.
    • (2006) Ann Oncol , vol.17 , pp. 663-667
    • Schmittel, A.1    Fischer Von Weikersthal, L.2    Sebastian, M.3
  • 66
    • 52049104938 scopus 로고    scopus 로고
    • Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: A randomized phase III trial
    • Hermes A, Bergman B, Bremnes R, et al. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial. J Clin Oncol 2008;26:4261-4267.
    • (2008) J Clin Oncol , vol.26 , pp. 4261-4267
    • Hermes, A.1    Bergman, B.2    Bremnes, R.3
  • 67
    • 78650513543 scopus 로고    scopus 로고
    • Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: Systematic review with meta-analysis
    • Lima JP, dos Santos LV, Sasse EC, et al. Camptothecins compared with etoposide in combination with platinum analog in extensive stage small cell lung cancer: systematic review with meta-analysis. J Thorac Oncol 2010;5:1986-1993.
    • (2010) J Thorac Oncol , vol.5 , pp. 1986-1993
    • Lima, J.P.1    Dos Santos, L.V.2    Sasse, E.C.3
  • 68
    • 0032998171 scopus 로고    scopus 로고
    • Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: Perceptible progress
    • Chute JP, Chen T, Feigal E, et al. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol 1999;17:1794-1801.
    • (1999) J Clin Oncol , vol.17 , pp. 1794-1801
    • Chute, J.P.1    Chen, T.2    Feigal, E.3
  • 69
    • 0029155454 scopus 로고
    • Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: A Hoosier Oncology Group study
    • Loehrer PJ Sr, Ansari R, Gonin R, et al. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study. J Clin Oncol 1995;13:2594-2599.
    • (1995) J Clin Oncol , vol.13 , pp. 2594-2599
    • Loehrer Sr., P.J.1    Ansari, R.2    Gonin, R.3
  • 70
    • 0035925071 scopus 로고    scopus 로고
    • Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: A French Federation of Cancer Institutes multicenter phase III randomized study
    • Pujol JL, Daures JP, Riviere A, et al. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study. J Natl Cancer Inst 2001;93:300-308.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 300-308
    • Pujol, J.L.1    Daures, J.P.2    Riviere, A.3
  • 71
    • 0027081441 scopus 로고
    • A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer
    • Miyamoto H, Nakabayashi T, Isobe H, et al. A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer. Oncology 1992;49:431-435.
    • (1992) Oncology , vol.49 , pp. 431-435
    • Miyamoto, H.1    Nakabayashi, T.2    Isobe, H.3
  • 72
    • 20544455089 scopus 로고    scopus 로고
    • Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B trial 9732
    • Niell HB, Herndon JE II, Miller AA, et al. Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B trial 9732. J Clin Oncol 2005;23:3752-3759.
    • (2005) J Clin Oncol , vol.23 , pp. 3752-3759
    • Niell, H.B.1    Herndon, J.E.I.I.2    Miller, A.A.3
  • 73
    • 0035871527 scopus 로고    scopus 로고
    • Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-A phase III trial of the eastern cooperative oncology group
    • Schiller JH, Adak S, Cella D, et al. Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593-a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:2114-2122.
    • (2001) J Clin Oncol , vol.19 , pp. 2114-2122
    • Schiller, J.H.1    Adak, S.2    Cella, D.3
  • 74
    • 0018569942 scopus 로고
    • A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate
    • Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-1733.
    • (1979) Cancer Treat Rep , vol.63 , pp. 1727-1733
    • Goldie, J.H.1    Coldman, A.J.2
  • 75
    • 0025898914 scopus 로고
    • Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer
    • Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst 1991;83:855-861.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 855-861
    • Fukuoka, M.1    Furuse, K.2    Saijo, N.3
  • 76
    • 0026500785 scopus 로고
    • Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
    • Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992;10:282-291.
    • (1992) J Clin Oncol , vol.10 , pp. 282-291
    • Roth, B.J.1    Johnson, D.H.2    Einhorn, L.H.3
  • 77
    • 0026033331 scopus 로고
    • Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer
    • Miles DW, Earl HM, Souhami RL, et al. Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. J Clin Oncol 1991;9:280-285.
    • (1991) J Clin Oncol , vol.9 , pp. 280-285
    • Miles, D.W.1    Earl, H.M.2    Souhami, R.L.3
  • 78
    • 0006663223 scopus 로고
    • Potential for long-term survival in extensive stage small-cell lung cancer (ESCLC) with CODE chemotherapy and radiotherapy [abstract]
    • Abstract 377
    • Murray N, Gelmon K, Shah A. Potential for long-term survival in extensive stage small-cell lung cancer (ESCLC) with CODE chemotherapy and radiotherapy [abstract]. Lung Cancer 1994;11(Suppl 1):99. Abstract 377.
    • (1994) Lung Cancer , vol.11 , Issue.SUPPL. 1 , pp. 99
    • Murray, N.1    Gelmon, K.2    Shah, A.3
  • 79
    • 0027488737 scopus 로고
    • Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party
    • Sculier JP, Paesmans M, Bureau G, et al. Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. J Clin Oncol 1993;11:1858-1865.
    • (1993) J Clin Oncol , vol.11 , pp. 1858-1865
    • Sculier, J.P.1    Paesmans, M.2    Bureau, G.3
  • 80
    • 0027948376 scopus 로고
    • Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: A Cancer Research Campaign trial
    • Souhami RL, Rudd R, Ruiz de Elvira MC, et al. Randomized trial comparing weekly versus 3-week chemotherapy in small-cell lung cancer: a Cancer Research Campaign trial. J Clin Oncol 1994;12:1806-1813.
    • (1994) J Clin Oncol , vol.12 , pp. 1806-1813
    • Souhami, R.L.1    Rudd, R.2    Ruiz De Elvira, M.C.3
  • 81
    • 8044245919 scopus 로고    scopus 로고
    • CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
    • Fukuoka M, Masuda N, Negoro S, et al. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer 1997;75:306-309.
    • (1997) Br J Cancer , vol.75 , pp. 306-309
    • Fukuoka, M.1    Masuda, N.2    Negoro, S.3
  • 82
    • 0032793437 scopus 로고    scopus 로고
    • Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group
    • Murray N, Livingston RB, Shepherd FA, et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol 1999;17:2300-2308.
    • (1999) J Clin Oncol , vol.17 , pp. 2300-2308
    • Murray, N.1    Livingston, R.B.2    Shepherd, F.A.3
  • 83
    • 0342627241 scopus 로고
    • Preclinical models for high-dose therapy
    • In: Armitage JO, Antman KH, eds. Baltimore, MD: Williams and Wilkins, 2nd Ed
    • Teicher BA. Preclinical models for high-dose therapy. In: Armitage JO, Antman KH, eds. High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells, 2nd ed. Baltimore, MD: Williams and Wilkins; 1995:14-42.
    • (1995) High-Dose Cancer Therapy: Pharmacology, Hematopoietins, Stem Cells , pp. 14-42
    • Teicher, B.A.1
  • 84
    • 0017701402 scopus 로고
    • Intensive chemotherapy of small cell bronchogenic carcinoma
    • Cohen MH, Creaven PJ, Fossieck BE Jr, et al. Intensive chemotherapy of small cell bronchogenic carcinoma. Cancer Treat Rep 1977;61:349-354.
    • (1977) Cancer Treat Rep , vol.61 , pp. 349-354
    • Cohen, M.H.1    Creaven, P.J.2    Fossieck Jr., B.E.3
  • 85
    • 0023610106 scopus 로고
    • A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
    • Johnson DH, Einhorn LH, Birch R, et al. A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1987;5:1731-1738.
    • (1987) J Clin Oncol , vol.5 , pp. 1731-1738
    • Johnson, D.H.1    Einhorn, L.H.2    Birch, R.3
  • 86
    • 0028149937 scopus 로고
    • Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
    • Ihde DC, Mulshine JL, Kramer BS, et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 1994;12:2022-2034.
    • (1994) J Clin Oncol , vol.12 , pp. 2022-2034
    • Ihde, D.C.1    Mulshine, J.L.2    Kramer, B.S.3
  • 87
    • 0027521597 scopus 로고
    • Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
    • Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848-1852.
    • (1993) N Engl J Med , vol.329 , pp. 1848-1852
    • Arriagada, R.1    Le Chevalier, T.2    Pignon, J.P.3
  • 88
    • 0033963545 scopus 로고    scopus 로고
    • Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party
    • Thatcher N, Girling DJ, Hopwood P, et al. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party. J Clin Oncol 2000;18:395-404.
    • (2000) J Clin Oncol , vol.18 , pp. 395-404
    • Thatcher, N.1    Girling, D.J.2    Hopwood, P.3
  • 89
    • 0025967769 scopus 로고
    • Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung
    • Klasa RJ, Murray N, Coldman AJ. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol 1991;9:499-508.
    • (1991) J Clin Oncol , vol.9 , pp. 499-508
    • Klasa, R.J.1    Murray, N.2    Coldman, A.J.3
  • 90
    • 0025800331 scopus 로고
    • Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
    • Crawford J, Ozer H, Stoller R, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-170.
    • (1991) N Engl J Med , vol.325 , pp. 164-170
    • Crawford, J.1    Ozer, H.2    Stoller, R.3
  • 91
    • 79957940921 scopus 로고    scopus 로고
    • Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: Results from the SALUTE trial
    • Spigel DR, Townley PM, Waterhouse DM, et al. Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial. J Clin Oncol 2011;29:2215-2222.
    • (2011) J Clin Oncol , vol.29 , pp. 2215-2222
    • Spigel, D.R.1    Townley, P.M.2    Waterhouse, D.M.3
  • 92
    • 74249115314 scopus 로고    scopus 로고
    • Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer
    • Spigel DR, Greco FA, Zubkus JD, et al. Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer. J Thorac Oncol 2009;4:1555-1560.
    • (2009) J Thorac Oncol , vol.4 , pp. 1555-1560
    • Spigel, D.R.1    Greco, F.A.2    Zubkus, J.D.3
  • 93
    • 73349099070 scopus 로고    scopus 로고
    • Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group study E3501
    • Horn L, Dahlberg SE, Sandler AB, et al. Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group study E3501. J Clin Oncol 2009;27:6006-6011.
    • (2009) J Clin Oncol , vol.27 , pp. 6006-6011
    • Horn, L.1    Dahlberg, S.E.2    Sandler, A.B.3
  • 94
    • 0347499622 scopus 로고    scopus 로고
    • Management of lung cancer in older adults
    • Hurria A, Kris MG. Management of lung cancer in older adults. CA Cancer J Clin 2003;53:325-341.
    • (2003) CA Cancer J Clin , vol.53 , pp. 325-341
    • Hurria, A.1    Kris, M.G.2
  • 95
    • 0030608237 scopus 로고    scopus 로고
    • Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: A stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party
    • Girling DJ. Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Lancet 1996;348:563-566.
    • (1996) Lancet , vol.348 , pp. 563-566
    • Girling, D.J.1
  • 96
    • 0030946011 scopus 로고    scopus 로고
    • Five-day oral etoposide treatment for advanced small-cell lung cancer: Randomized comparison with intravenous chemotherapy
    • Souhami RL, Spiro SG, Rudd RM, et al. Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst 1997;89:577-580.
    • (1997) J Natl Cancer Inst , vol.89 , pp. 577-580
    • Souhami, R.L.1    Spiro, S.G.2    Rudd, R.M.3
  • 97
    • 3042826879 scopus 로고    scopus 로고
    • Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with eastern cooperative oncology group performance status of 2, or age >= 70 years
    • Neubauer M, Schwartz J, Caracandas J, et al. Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with eastern cooperative oncology group performance status of 2, or age >= 70 years. J Clin Oncol 2004;22:1872-1877.
    • (2004) J Clin Oncol , vol.22 , pp. 1872-1877
    • Neubauer, M.1    Schwartz, J.2    Caracandas, J.3
  • 98
    • 0031803819 scopus 로고    scopus 로고
    • New combination of the old drugs for elderly patients with small-cell lung cancer: A phase II study of the PAVE regimen
    • Westeel V, Murray N, Gelmon K, et al. New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen. J Clin Oncol 1998;16:1940-1947.
    • (1998) J Clin Oncol , vol.16 , pp. 1940-1947
    • Westeel, V.1    Murray, N.2    Gelmon, K.3
  • 99
    • 0032703877 scopus 로고    scopus 로고
    • Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer
    • Okamoto H, Watanabe K, Nishiwaki Y, et al. Phase II study of area under the plasma-concentration-versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol 1999;17:3540-3545.
    • (1999) J Clin Oncol , vol.17 , pp. 3540-3545
    • Okamoto, H.1    Watanabe, K.2    Nishiwaki, Y.3
  • 100
    • 0034866074 scopus 로고    scopus 로고
    • Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer
    • Matsui K, Masuda N, Yana T, et al. Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer. Intern Med 2001;40:603-606.
    • (2001) Intern Med , vol.40 , pp. 603-606
    • Matsui, K.1    Masuda, N.2    Yana, T.3
  • 101
    • 0031726506 scopus 로고    scopus 로고
    • Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer
    • Murray N, Grafton C, Shah A, et al. Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer. J Clin Oncol 1998;16:3323-3328.
    • (1998) J Clin Oncol , vol.16 , pp. 3323-3328
    • Murray, N.1    Grafton, C.2    Shah, A.3
  • 102
    • 73349141727 scopus 로고    scopus 로고
    • New advances in the second-line treatment of small cell lung cancer
    • Hurwitz JL, McCoy F, Scullin P, Fennell DA. New advances in the second-line treatment of small cell lung cancer. Oncologist 2009;14:986-994.
    • (2009) Oncologist , vol.14 , pp. 986-994
    • Hurwitz, J.L.1    McCoy, F.2    Scullin, P.3    Fennell, D.A.4
  • 103
    • 41749087812 scopus 로고    scopus 로고
    • Management of recurrent small cell lung cancer
    • Schneider BJ. Management of recurrent small cell lung cancer. J Natl Compr Canc Netw 2008;6:323-331.
    • (2008) J Natl Compr Canc Netw , vol.6 , pp. 323-331
    • Schneider, B.J.1
  • 104
    • 84857073822 scopus 로고    scopus 로고
    • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    • Pietanza MC, Kadota K, Huberman K, et al. Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker. Clin Cancer Res 2012;18:1138-1145.
    • (2012) Clin Cancer Res , vol.18 , pp. 1138-1145
    • Pietanza, M.C.1    Kadota, K.2    Huberman, K.3
  • 105
    • 34247850949 scopus 로고    scopus 로고
    • Chemotherapy for relapsed small cell lung cancer: A systematic review and practice guideline
    • Cheng S, Evans WK, Stys-Norman D, Shepherd FA. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 2007;2:348-354.
    • (2007) J Thorac Oncol , vol.2 , pp. 348-354
    • Cheng, S.1    Evans, W.K.2    Stys-Norman, D.3    Shepherd, F.A.4
  • 106
    • 0034909054 scopus 로고    scopus 로고
    • New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer
    • Ettinger DS. New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer. Semin Oncol 2001;28:27-29.
    • (2001) Semin Oncol , vol.28 , pp. 27-29
    • Ettinger, D.S.1
  • 107
    • 0033996043 scopus 로고    scopus 로고
    • New chemotherapy agents for small cell lung cancer
    • Kelly K. New chemotherapy agents for small cell lung cancer. Chest 2000;117:156S-162S.
    • (2000) Chest , vol.117
    • Kelly, K.1
  • 108
    • 0037504528 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group trial 1597
    • Masters GA, Declerck L, Blanke C, et al. Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group trial 1597. J Clin Oncol 2003;21:1550-1555.
    • (2003) J Clin Oncol , vol.21 , pp. 1550-1555
    • Masters, G.A.1    Declerck, L.2    Blanke, C.3
  • 109
    • 0033044111 scopus 로고    scopus 로고
    • Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer
    • von Pawel J, Schiller JH, Shepherd FA, et al. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol 1999;17:658-667.
    • (1999) J Clin Oncol , vol.17 , pp. 658-667
    • Von Pawel, J.1    Schiller, J.H.2    Shepherd, F.A.3
  • 110
    • 34247218552 scopus 로고    scopus 로고
    • Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
    • O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006;24:5441-5447.
    • (2006) J Clin Oncol , vol.24 , pp. 5441-5447
    • O'Brien, M.E.1    Ciuleanu, T.E.2    Tsekov, H.3
  • 111
    • 34249941781 scopus 로고    scopus 로고
    • Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer
    • Eckardt JR, von Pawel J, Pujol JL, et al. Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. J Clin Oncol 2007;25:2086-2092.
    • (2007) J Clin Oncol , vol.25 , pp. 2086-2092
    • Eckardt, J.R.1    Von Pawel, J.2    Pujol, J.L.3
  • 112
    • 33750185826 scopus 로고    scopus 로고
    • Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
    • Huber RM, Reck M, Gosse H, et al. Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer. Eur Respir J 2006;27:1183-1189.
    • (2006) Eur Respir J , vol.27 , pp. 1183-1189
    • Huber, R.M.1    Reck, M.2    Gosse, H.3
  • 113
    • 34249735284 scopus 로고    scopus 로고
    • A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer
    • Shah C, Ready N, Perry M, et al. A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer. Lung Cancer 2007;57:84-88.
    • (2007) Lung Cancer , vol.57 , pp. 84-88
    • Shah, C.1    Ready, N.2    Perry, M.3
  • 114
    • 33846442125 scopus 로고    scopus 로고
    • Topotecan: Weekly intravenous (IV) schedule similar to standard 5-day IV schedule as second-line therapy for relapsed small cell lung cancer (SCLC)-A Minnie Pearl Cancer Research Network phase II trial [abstract]
    • Abstract 7083
    • Shipley DL, Hainsworth JD, Spigel DR, et al. Topotecan: weekly intravenous (IV) schedule similar to standard 5-day IV schedule as second-line therapy for relapsed small cell lung cancer (SCLC)-a Minnie Pearl Cancer Research Network phase II trial [abstract]. J Clin Oncol 2006;24(Suppl 18):Abstract 7083.
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL. 18
    • Shipley, D.L.1    Hainsworth, J.D.2    Spigel, D.R.3
  • 115
    • 77956396425 scopus 로고    scopus 로고
    • Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer
    • Ettinger DS, Jotte R, Lorigan P, et al. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol 2010;28:2598-2603.
    • (2010) J Clin Oncol , vol.28 , pp. 2598-2603
    • Ettinger, D.S.1    Jotte, R.2    Lorigan, P.3
  • 116
    • 56749131841 scopus 로고    scopus 로고
    • Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402
    • Inoue A, Sugawara S, Yamazaki K, et al. Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol 2008;26:5401-5406.
    • (2008) J Clin Oncol , vol.26 , pp. 5401-5406
    • Inoue, A.1    Sugawara, S.2    Yamazaki, K.3
  • 117
    • 34247197121 scopus 로고    scopus 로고
    • Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301
    • Onoda S, Masuda N, Seto T, et al. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol 2006;24:5448-5453.
    • (2006) J Clin Oncol , vol.24 , pp. 5448-5453
    • Onoda, S.1    Masuda, N.2    Seto, T.3
  • 118
    • 60649090249 scopus 로고    scopus 로고
    • Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer
    • Shimokawa T, Shibuya M, Kitamura K, et al. Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer. Int J Clin Oncol 2009;14:63-69.
    • (2009) Int J Clin Oncol , vol.14 , pp. 63-69
    • Shimokawa, T.1    Shibuya, M.2    Kitamura, K.3
  • 119
    • 79951993031 scopus 로고    scopus 로고
    • Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy
    • Jotte R, Conkling P, Reynolds C, et al. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy. J Clin Oncol 2011;29:287-293.
    • (2011) J Clin Oncol , vol.29 , pp. 287-293
    • Jotte, R.1    Conkling, P.2    Reynolds, C.3
  • 120
    • 2442617202 scopus 로고    scopus 로고
    • 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of Cancer and Leukemia Group B study 39808
    • Bogart JA, Herndon JE II, Lyss AP, et al. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Biol Phys 2004;59:460-468.
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 460-468
    • Bogart, J.A.1    Herndon, J.E.I.I.2    Lyss, A.P.3
  • 121
    • 0028357990 scopus 로고
    • Limited-stage small-cell lung cancer: Patterns of intrathoracic recurrence and the implications for thoracic radiotherapy
    • Liengswangwong V, Bonner JA, Shaw EG, et al. Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 1994;12:496-502.
    • (1994) J Clin Oncol , vol.12 , pp. 496-502
    • Liengswangwong, V.1    Bonner, J.A.2    Shaw, E.G.3
  • 122
    • 20144388394 scopus 로고    scopus 로고
    • Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer
    • Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235:208-215.
    • (2005) Radiology , vol.235 , pp. 208-215
    • Kim, T.H.1    Cho, K.H.2    Pyo, H.R.3
  • 123
    • 65749102667 scopus 로고    scopus 로고
    • Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy
    • Rose J, Rodrigues G, Yaremko B, et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 2009;91:282-287.
    • (2009) Radiother Oncol , vol.91 , pp. 282-287
    • Rose, J.1    Rodrigues, G.2    Yaremko, B.3
  • 124
    • 81855206076 scopus 로고    scopus 로고
    • Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
    • Kong FM, Ritter T, Quint DJ, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442-1457.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 1442-1457
    • Kong, F.M.1    Ritter, T.2    Quint, D.J.3
  • 125
    • 83955161774 scopus 로고    scopus 로고
    • Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer
    • Shirvani SM, Komaki R, Heymach JV, et al. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012;82:e91-97.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82
    • Shirvani, S.M.1    Komaki, R.2    Heymach, J.V.3
  • 126
    • 0033016449 scopus 로고    scopus 로고
    • Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study
    • Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999;17:2092-2099.
    • (1999) J Clin Oncol , vol.17 , pp. 2092-2099
    • Jeremic, B.1    Shibamoto, Y.2    Nikolic, N.3
  • 127
    • 0028910241 scopus 로고
    • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
    • Arriagada R, Le Chevalier T, Borie F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-190.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 183-190
    • Arriagada, R.1    Le Chevalier, T.2    Borie, F.3
  • 128
    • 0345062339 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
    • Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999;341:476-484.
    • (1999) N Engl J Med , vol.341 , pp. 476-484
    • Auperin, A.1    Arriagada, R.2    Pignon, J.P.3
  • 129
    • 34547937885 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in extensive small-cell lung cancer
    • Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007;357:664-672.
    • (2007) N Engl J Med , vol.357 , pp. 664-672
    • Slotman, B.1    Faivre-Finn, C.2    Kramer, G.3
  • 130
    • 77955358817 scopus 로고    scopus 로고
    • Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: Current concepts and approaches
    • Marsh JC, Gielda BT, Herskovic AM, Abrams RA. Cognitive sparing during the administration of whole brain radiotherapy and prophylactic cranial irradiation: current concepts and approaches. J Oncol 2010;2010:198-208.
    • (2010) J Oncol , vol.2010 , pp. 198-208
    • Marsh, J.C.1    Gielda, B.T.2    Herskovic, A.M.3    Abrams, R.A.4
  • 131
    • 79951936926 scopus 로고    scopus 로고
    • Radiotherapy in small-cell lung cancer: Lessons learned and future directions
    • Slotman BJ, Senan S. Radiotherapy in small-cell lung cancer: lessons learned and future directions. Int J Radiat Oncol Biol Phys 2011;79:998-1003.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , pp. 998-1003
    • Slotman, B.J.1    Senan, S.2
  • 132
    • 65449145578 scopus 로고    scopus 로고
    • Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): A randomised clinical trial
    • Le Pechoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009;10:467-474.
    • (2009) Lancet Oncol , vol.10 , pp. 467-474
    • Le Pechoux, C.1    Dunant, A.2    Senan, S.3
  • 133
    • 79961127734 scopus 로고    scopus 로고
    • Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer
    • Wolfson AH, Bae K, Komaki R, et al. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:77-84.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 77-84
    • Wolfson, A.H.1    Bae, K.2    Komaki, R.3
  • 134
    • 58149346191 scopus 로고    scopus 로고
    • Prophylactic cranial irradiation in extensive disease small-cell lung cancer: Short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups
    • Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms-results of an international phase III randomized controlled trial by the EORTC radiation oncology and lung cancer groups. J Clin Oncol 2009;27:78-84.
    • (2009) J Clin Oncol , vol.27 , pp. 78-84
    • Slotman, B.J.1    Mauer, M.E.2    Bottomley, A.3
  • 135
    • 70350757850 scopus 로고    scopus 로고
    • 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: Results of a phase III randomized multicentre Italian trial
    • Maranzano E, Trippa F, Casale M, et al. 8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009;93:174-179.
    • (2009) Radiother Oncol , vol.93 , pp. 174-179
    • Maranzano, E.1    Trippa, F.2    Casale, M.3
  • 136
    • 79951956249 scopus 로고    scopus 로고
    • Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline
    • Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965-976.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , pp. 965-976
    • Lutz, S.1    Berk, L.2    Chang, E.3
  • 138
    • 84865179740 scopus 로고    scopus 로고
    • Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
    • Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012;4:CD003869.
    • (2012) Cochrane Database Syst Rev , vol.4
    • Tsao, M.N.1    Lloyd, N.2    Wong, R.K.3
  • 139
    • 0028797891 scopus 로고
    • Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years
    • Johnson BE, Linnoila RI, Williams JP, et al. Risk of second aerodigestive cancers increases in patients who survive free of small-cell lung cancer for more than 2 years. J Clin Oncol 1995;13:101-111.
    • (1995) J Clin Oncol , vol.13 , pp. 101-111
    • Johnson, B.E.1    Linnoila, R.I.2    Williams, J.P.3
  • 140
    • 0032538039 scopus 로고    scopus 로고
    • Second lung cancers in patients after treatment for an initial lung cancer
    • Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-1345.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1335-1345
    • Johnson, B.E.1
  • 141
    • 0027438775 scopus 로고
    • Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
    • Richardson GE, Tucker MA, Venzon DJ, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-390.
    • (1993) Ann Intern Med , vol.119 , pp. 383-390
    • Richardson, G.E.1    Tucker, M.A.2    Venzon, D.J.3
  • 142
    • 7344228962 scopus 로고    scopus 로고
    • Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation
    • Kawahara M, Ushijima S, Kamimori T, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer 1998;78:409-412.
    • (1998) Br J Cancer , vol.78 , pp. 409-412
    • Kawahara, M.1    Ushijima, S.2    Kamimori, T.3
  • 143
    • 75749108918 scopus 로고    scopus 로고
    • Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis
    • Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
    • (2010) BMJ , vol.340
    • Parsons, A.1    Daley, A.2    Begh, R.3    Aveyard, P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.